Latest news with #XbraneBiopharma
Yahoo
4 days ago
- Business
- Yahoo
3 European Growth Companies With Insider Ownership Seeing Up To 114% Earnings Growth
As European markets navigate a landscape of mixed stock index performances and ongoing trade discussions, investors are keenly observing growth opportunities within the region. In this context, companies with high insider ownership often draw attention due to their potential for alignment between management and shareholder interests, making them intriguing candidates in today's market environment. Top 10 Growth Companies With High Insider Ownership In Europe Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 43.3% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 94.5% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 62.3% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 214 stocks from our Fast Growing European Companies With High Insider Ownership screener. Here's a peek at a few of the choices from the screener. Paratus Energy Services Simply Wall St Growth Rating: ★★★★☆☆ Overview: Paratus Energy Services Ltd. operates through its subsidiaries to provide drilling services with a fleet of jack-up rigs under contracts in Mexico, and it has a market capitalization of NOK6.35 billion. Operations: The company's revenue segments include $205 million from Fontis and $197.80 million from Seagems. Insider Ownership: 30.3% Earnings Growth Forecast: 36.5% p.a. Paratus Energy Services has significant growth potential, with earnings forecasted to grow at 36.5% annually, outpacing the Norwegian market's 10.8%. Despite a decline in Q1 sales and net income compared to last year, the company maintains a high return on equity projection of 96.1% within three years. However, revenue growth is expected to lag behind the market at just 0.9%. The stock trades significantly below its estimated fair value but faces challenges with interest coverage from earnings. Dive into the specifics of Paratus Energy Services here with our thorough growth forecast report. According our valuation report, there's an indication that Paratus Energy Services' share price might be on the cheaper side. Devyser Diagnostics Simply Wall St Growth Rating: ★★★★★☆ Overview: Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing related to hereditary diseases, oncology, and post-transplantation monitoring across multiple regions including Europe, the Middle East, Africa, the Americas, and Asia with a market cap of approximately SEK2.52 billion. Operations: The company's revenue is primarily derived from the sale of diagnostic kits and equipment, amounting to SEK235.10 million. Insider Ownership: 35.4% Earnings Growth Forecast: 115.0% p.a. Devyser Diagnostics shows promising growth potential, with revenue projected to grow at 27.7% annually, significantly outpacing the Swedish market's 5.2%. The company recently reported a turnaround in Q2 earnings, achieving SEK 1.3 million net income compared to a loss last year. Devyser's innovative product launches in genomic blood typing and HLA loss detection bolster its research capabilities and market position. Despite low return on equity forecasts, profitability is expected within three years. Unlock comprehensive insights into our analysis of Devyser Diagnostics stock in this growth report. In light of our recent valuation report, it seems possible that Devyser Diagnostics is trading beyond its estimated value. Surgical Science Sweden Simply Wall St Growth Rating: ★★★★☆☆ Overview: Surgical Science Sweden AB (publ) specializes in developing and marketing virtual reality simulators for evidence-based medical training globally, with a market cap of SEK8.08 billion. Operations: The company generates revenue through two main segments: Industry/OEM, contributing SEK460.22 million, and Educational Products, accounting for SEK486.31 million. Insider Ownership: 14.8% Earnings Growth Forecast: 32.5% p.a. Surgical Science Sweden demonstrates strong growth potential with earnings projected to grow 32.54% annually, outpacing the Swedish market's 16.9%. Recent Q1 results show sales of SEK 250.69 million and net income of SEK 33.24 million, reflecting positive year-over-year growth. Despite a lower profit margin than last year, insider activity remains positive with more shares bought than sold recently. The company trades at a significant discount to its estimated fair value, indicating potential investment appeal amidst board leadership changes. Delve into the full analysis future growth report here for a deeper understanding of Surgical Science Sweden. Our expertly prepared valuation report Surgical Science Sweden implies its share price may be too high. Turning Ideas Into Actions Click through to start exploring the rest of the 211 Fast Growing European Companies With High Insider Ownership now. Ready To Venture Into Other Investment Styles? Outshine the giants: these 20 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include OB:PLSV OM:DVYSR and OM:SUS. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
Yahoo
5 days ago
- Business
- Yahoo
European Growth Companies With High Insider Ownership To Watch
As the European markets navigate a landscape of mixed stock index performances and ongoing trade discussions with the U.S., investors are keenly observing economic indicators such as inflation and industrial output. In this environment, growth companies with substantial insider ownership can be particularly appealing, as they often signal strong internal confidence and alignment of interests between management and shareholders. Top 10 Growth Companies With High Insider Ownership In Europe Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 43.3% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 94.5% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 62.3% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 214 stocks from our Fast Growing European Companies With High Insider Ownership screener. Here's a peek at a few of the choices from the screener. PostNL Simply Wall St Growth Rating: ★★★★☆☆ Overview: PostNL N.V. offers postal and logistics services to businesses and consumers in the Netherlands, Europe, and internationally, with a market cap of €536.66 million. Operations: The company's revenue is primarily derived from its Parcels segment, generating €2.39 billion, and the Mail in The Netherlands segment, contributing €1.33 billion. Insider Ownership: 35.1% Earnings Growth Forecast: 32.9% p.a. PostNL is experiencing significant earnings growth, forecasted at 32.88% annually, outpacing the Dutch market's 9.1%. Despite a recent net loss of €17 million for Q1 2025, this marks an improvement from the previous year's €20 million loss. However, revenue growth remains modest at 1.9% per year and below the market average of 7.3%. The company faces challenges with high debt levels and volatile share prices but trades significantly below its estimated fair value. Delve into the full analysis future growth report here for a deeper understanding of PostNL. Upon reviewing our latest valuation report, PostNL's share price might be too optimistic. Medicover Simply Wall St Growth Rating: ★★★★★☆ Overview: Medicover AB (publ) offers healthcare and diagnostic services in Poland, Sweden, and internationally, with a market cap of SEK43.03 billion. Operations: The company's revenue segments include healthcare services at €1.17 billion and diagnostic services at €0.80 billion. Insider Ownership: 11.2% Earnings Growth Forecast: 23.5% p.a. Medicover shows strong growth potential, with earnings forecasted to grow significantly at 23.5% annually, surpassing the Swedish market's average. Recent earnings reports highlight a substantial increase in net income and revenue for the first half of 2025. Despite no substantial insider buying recently, insider transactions have been more purchases than sales. Medicover's innovative MRD assay development marks a promising advancement in personalized cancer treatment, potentially enhancing its market position and supporting future growth prospects. Take a closer look at Medicover's potential here in our earnings growth report. Our expertly prepared valuation report Medicover implies its share price may be too high. Yubico Simply Wall St Growth Rating: ★★★★★☆ Overview: Yubico AB offers authentication solutions for computers, networks, and online services with a market cap of SEK12 billion. Operations: The company's revenue primarily comes from its Security Software & Services segment, totaling SEK2.45 billion. Insider Ownership: 36.5% Earnings Growth Forecast: 23.9% p.a. Yubico demonstrates strong growth potential with earnings expected to grow significantly at 23.9% annually, outpacing the Swedish market. Recent expansions, including YubiKey as a Service in the EU and increased delivery coverage, enhance its market reach and operational efficiency against phishing threats. Despite a decline in net income for Q1 2025, insider buying has been substantial recently, indicating confidence in future prospects. The company trades at good value compared to peers within the industry. Click to explore a detailed breakdown of our findings in Yubico's earnings growth report. Upon reviewing our latest valuation report, Yubico's share price might be too pessimistic. Where To Now? Click here to access our complete index of 214 Fast Growing European Companies With High Insider Ownership. Want To Explore Some Alternatives? This technology could replace computers: discover the 27 stocks are working to make quantum computing a reality. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ENXTAM:PNL OM:MCOV B and OM:YUBICO. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
7 days ago
- Business
- Yahoo
European Growth Companies With Strong Insider Ownership
As European markets navigate a complex landscape of mixed economic signals and trade discussions, investors are keenly watching for opportunities that align with current conditions. In this environment, growth companies with strong insider ownership can offer a compelling proposition, as they often reflect confidence from those most familiar with the business's potential and challenges. Top 10 Growth Companies With High Insider Ownership In Europe Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 43.3% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 94.5% Elliptic Laboratories (OB:ELABS) 24.4% 79% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 62.3% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 214 stocks from our Fast Growing European Companies With High Insider Ownership screener. Let's uncover some gems from our specialized screener. Just Eat Simply Wall St Growth Rating: ★★★★☆☆ Overview: Just Eat N.V. is a global online food delivery company with a market cap of €3.97 billion. Operations: The company's revenue is generated from various regions, with €437 million from North America, €1.39 billion from the UK and Ireland, €1.37 billion from Northern Europe, and €372 million from Southern Europe & Australia. Insider Ownership: 11.1% Just Eat shows potential as a growth company with high insider ownership, supported by its forecasted earnings growth of 97.35% per year and expected profitability within three years, surpassing average market growth. Despite trading at 57.8% below estimated fair value, revenue is projected to grow at 8.6% annually, faster than the Dutch market rate. Recent events include presentations at London Tech Week and an upcoming shareholders meeting in July 2025. Navigate through the intricacies of Just Eat with our comprehensive analyst estimates report here. Our comprehensive valuation report raises the possibility that Just Eat is priced lower than what may be justified by its financials. OVH Groupe Simply Wall St Growth Rating: ★★★★★☆ Overview: OVH Groupe S.A. is a global provider of public and private cloud services, shared hosting, and dedicated server solutions, with a market cap of approximately €1.67 billion. Operations: The company's revenue segments include Public Cloud (€198.23 million), Private Cloud (€655.28 million), and Web Cloud & Other (€189.46 million). Insider Ownership: 12.6% OVH Groupe's growth prospects are underscored by its forecasted earnings increase of 69.1% annually, significantly outpacing the French market. Recent revenue figures show a rise to €271.9 million for the quarter, reflecting steady progress. The strategic partnership with Crayon enhances OVHcloud's position in sustainable cloud solutions across Europe and beyond. However, investor caution may be warranted due to high share price volatility and recent board changes, including resignations and new appointments. Click here to discover the nuances of OVH Groupe with our detailed analytical future growth report. Our valuation report unveils the possibility OVH Groupe's shares may be trading at a premium. Zalando Simply Wall St Growth Rating: ★★★★☆☆ Overview: Zalando SE operates an online platform for fashion and lifestyle products in Europe, with a market cap of approximately €7.17 billion. Operations: The company's revenue segments include €977.50 million from B2B and €9.81 billion from B2C, with a reconciliation amount of -€39.10 million. Insider Ownership: 10.3% Zalando's growth potential is highlighted by its forecasted earnings increase of 22.7% annually, surpassing the German market average. The company confirmed its 2025 revenue growth guidance between 4% and 9%, with recent Q1 sales at €2.42 billion and net income of €9.9 million. Despite trading significantly below estimated fair value, its return on equity is projected to be modest at 13.8%. Recent insider activity shows no substantial buying or selling over the past three months. Get an in-depth perspective on Zalando's performance by reading our analyst estimates report here. Our valuation report here indicates Zalando may be undervalued. Make It Happen Investigate our full lineup of 214 Fast Growing European Companies With High Insider Ownership right here. Searching for a Fresh Perspective? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ENXTAM:TKWY ENXTPA:OVH and XTRA:ZAL. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11-07-2025
- Business
- Yahoo
European Growth Stocks With High Insider Ownership July 2025
As of July 2025, the European stock market has shown mixed performance, with the pan-European STOXX Europe 600 Index remaining relatively flat and major indexes like France's CAC 40 and Italy's FTSE MIB posting modest gains. Amidst this backdrop of steady economic indicators such as eurozone inflation hitting the ECB's target and a stable labor market, investors are increasingly looking towards growth companies with high insider ownership as potential opportunities for long-term value creation. Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Pharma Mar (BME:PHM) 11.8% 44.9% MilDef Group (OM:MILDEF) 13.7% 75.6% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% Marinomed Biotech (WBAG:MARI) 29.7% 20.2% KebNi (OM:KEBNI B) 38.3% 94.5% Elliptic Laboratories (OB:ELABS) 24.4% 79% Circus (XTRA:CA1) 24.7% 94.8% Bonesupport Holding (OM:BONEX) 10.4% 57.5% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 214 stocks from our Fast Growing European Companies With High Insider Ownership screener. Underneath we present a selection of stocks filtered out by our screen. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Ferrari N.V. is involved in the design, engineering, production, and sale of luxury performance sports cars globally, with a market cap of approximately €75.68 billion. Operations: The company generates revenue primarily from its luxury performance sports car segment, amounting to approximately €6.88 billion. Insider Ownership: 10.6% Return On Equity Forecast: 35% (2028 estimate) Ferrari's strong insider ownership aligns with its growth trajectory, as evidenced by a 21% earnings increase over the past year and projected revenue growth of 7.2% annually, outpacing the Italian market. Recent financials show first-quarter sales of €1.79 billion and net income of €411.64 million. The company has completed a significant share buyback program worth €1.62 billion and expects full-year revenues to exceed €7 billion, reflecting robust operational performance and strategic shareholder value initiatives. Click here and access our complete growth analysis report to understand the dynamics of Ferrari. Our valuation report here indicates Ferrari may be overvalued. Simply Wall St Growth Rating: ★★★★★☆ Overview: EQT AB (publ) is a global private equity and venture capital firm focusing on private capital and real asset segments, with a market cap of approximately SEK400 billion. Operations: The company's revenue segments include €41.50 million from Central, €951.90 million from Real Assets, and €1.36 billion from Private Capital. Insider Ownership: 12.6% Return On Equity Forecast: 22% (2027 estimate) EQT's high insider ownership supports its growth potential, with earnings projected to grow significantly at 22.8% annually, outpacing the Swedish market. Recent insider activity shows substantial share purchases, indicating confidence in future prospects. The firm is actively engaged in strategic M&A discussions and asset sales, such as its Italian unit of Radius Global Infrastructure valued over €1 billion ($1.2 billion). EQT's inclusion in the OMX Stockholm 30 Index further underscores its market prominence and strategic initiatives to enhance shareholder value. Get an in-depth perspective on EQT's performance by reading our analyst estimates report here. Upon reviewing our latest valuation report, EQT's share price might be too optimistic. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Sonova Holding AG is a Swiss company that manufactures and sells hearing care solutions for children and adults across various regions including the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with a market cap of CHF14.10 billion. Operations: Sonova's revenue is primarily derived from its Hearing Instruments segment, which generated CHF3.57 billion, and its Cochlear Implants segment, which contributed CHF307.50 million. Insider Ownership: 17.4% Return On Equity Forecast: 25% (2028 estimate) Sonova Holding's growth prospects are supported by forecasted revenue growth of 5.4% annually, outpacing the Swiss market. Despite no recent insider trading activity, its valuation is attractive compared to peers. Leadership changes include Eric Bernard as incoming CEO, bringing extensive industry experience. The company anticipates sales increase between 5% and 9% for 2025-2026, though currency fluctuations may impact reported figures in Swiss francs by approximately four percentage points. Delve into the full analysis future growth report here for a deeper understanding of Sonova Holding. Insights from our recent valuation report point to the potential undervaluation of Sonova Holding shares in the market. Delve into our full catalog of 214 Fast Growing European Companies With High Insider Ownership here. Searching for a Fresh Perspective? Outshine the giants: these 23 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include BIT:RACE OM:EQT and SWX:SOON. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-06-2025
- Business
- Yahoo
3 European Growth Companies With Insider Ownership Up To 24%
As the European market navigates through geopolitical tensions and economic uncertainties, reflected by the recent declines in major indices like the STOXX Europe 600, investors are increasingly seeking stability and growth potential. In this environment, companies with high insider ownership can be particularly appealing as they often indicate management's confidence in their business prospects. Name Insider Ownership Earnings Growth Xbrane Biopharma (OM:XBRANE) 21.8% 56.8% Redelfi (BIT:RDF) 12.1% 37.3% Pharma Mar (BME:PHM) 11.8% 44.9% MedinCell (ENXTPA:MEDCL) 13.9% 130.8% KebNi (OM:KEBNI B) 38.3% 67% Elliptic Laboratories (OB:ELABS) 24.4% 79% Diamyd Medical (OM:DMYD B) 11.9% 93% CTT Systems (OM:CTT) 17.5% 34.2% Bonesupport Holding (OM:BONEX) 10.4% 58.6% Bergen Carbon Solutions (OB:BCS) 12% 63.2% Click here to see the full list of 190 stocks from our Fast Growing European Companies With High Insider Ownership screener. We'll examine a selection from our screener results. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Lectra SA offers industrial intelligence solutions for the fashion, automotive, furniture markets, and other industries globally, with a market cap of €940.56 million. Operations: The company's revenue is segmented as follows: €176.26 million from the Americas, €134.84 million from Asia-Pacific, and €220.46 million from EMEA (Europe, Middle East and Africa). Insider Ownership: 12.7% Lectra's recent expansion of its Valia Fashion platform into new markets like Mexico and Brazil underscores its growth strategy in the fashion industry's shift to Industry 4.0. Despite a modest revenue growth forecast of 5.9% annually, Lectra's earnings are expected to grow significantly at 21.42% per year, outpacing the French market average. The company is exploring M&A opportunities to strengthen its position further while trading below estimated fair value, indicating potential for future appreciation. Delve into the full analysis future growth report here for a deeper understanding of Lectra. Our comprehensive valuation report raises the possibility that Lectra is priced lower than what may be justified by its financials. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Verve Group SE is a digital media company that provides ad-software solutions in North America and Europe, with a market cap of €528.13 million. Operations: The company's revenue is derived from two main segments: Demand Side Platforms (DSP), generating €117.61 million, and Supply Side Platforms (SSP), contributing €401.53 million. Insider Ownership: 24.5% Verve Group SE's recent financial activities, including a SEK 360.024 million follow-on equity offering and board changes, highlight its dynamic growth strategy. Despite a drop in net income to €0.186 million for Q1 2025, revenue increased to €114.91 million compared to the previous year. The company anticipates annual revenues between €530 million and €565 million for 2025, with substantial insider buying indicating confidence in its growth potential despite volatile share prices and lower profit margins than last year. Take a closer look at Verve Group's potential here in our earnings growth report. According our valuation report, there's an indication that Verve Group's share price might be on the cheaper side. Simply Wall St Growth Rating: ★★★★☆☆ Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €1.99 billion. Operations: The company's revenue is divided into two main segments: DACH, generating €2.06 billion, and International, contributing €464.53 million. Insider Ownership: 13.4% Redcare Pharmacy's growth potential is underscored by substantial insider buying, indicating confidence despite a volatile share price. The company reported Q1 2025 sales of €717.29 million, up from €560.22 million the previous year, though it incurred a net loss of €10.82 million. With revenue forecasted to grow at 16% annually and expected profitability within three years, Redcare remains undervalued at 69% below its estimated fair value amid recent board changes enhancing strategic oversight. Click here to discover the nuances of Redcare Pharmacy with our detailed analytical future growth report. The analysis detailed in our Redcare Pharmacy valuation report hints at an inflated share price compared to its estimated value. Unlock more gems! Our Fast Growing European Companies With High Insider Ownership screener has unearthed 187 more companies for you to here to unveil our expertly curated list of 190 Fast Growing European Companies With High Insider Ownership. Interested In Other Possibilities? Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years. Companies discussed in this article include ENXTPA:LSS XTRA:M8G and XTRA:RDC. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
